Psilocybin, moralization and psychotherapy: a scoping review and a case report

Psychedelic substances show promise for psychiatric treatment, but their therapeutic effect is not purely pharmacological; they enhance psychotherapy. A systematic review and case study demonstrate that integrating psychedelics with psychotherapeutic interventions is essential. The paper examines the historical context, mechanism of action, and evidence for treating depression, emphasizing methodological rigor and ethical standards. It advocates for psychedelic treatments as legitimate alternatives alongside traditional therapies, potentially shifting psychiatric care paradigms.

Study at a glance

Abstract

The resurgence of interest in psychedelic substances for psychiatric treatment has sparked both excitement and scepticism within the scientific community. This paper addresses the moralisation and hype surrounding psychedelic therapies. Through a systematic review of the literature and a detailed case study, we illustrate that the therapeutic effect of psychedelics is not solely pharmacological but is instead facilitated by their ability to enhance psychotherapy. The paper explores the historical context of psychedelics in psychiatry, their mechanism of action, and evidence of their efficacy in treating depression. We highlight the necessity of integrating psychedelics with psychotherapeutic interventions and emphasise the importance of methodological rigour and ethical standards in psychedelic research and practice. By presenting an informed understanding of psychedelic treatments, we advocate for their consideration as legitimate alternatives alongside traditional therapies, offering a potential paradigm shift in psychiatric care.